Skip to main content
CDC Website

HIV and AIDS

The National HIV Prevention Inventory: The State of HIV Prevention Across the U.S.

This report is based on a survey of 65 state, territorial, and local health departments, including all 50 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the six U.S.-affiliated Pacific jurisdictions (American Samoa, Federated States of Micronesia, Guam, Marshall Islands, Northern Mariana Islands, and the Republic of Palau), and six directly funded localities (Chicago, Houston, Los Angeles County, New York City, Philadelphia, and San Francisco).

Memento Therapeutique du VIH/SIDA en Afrique

This report is a manual on antiretroviral treatment and care of HIV infected patients in African settings. This second version of the manual was written by a team of doctors and researchers in France. It provides concise updated information on types of antiretroviral drugs, post-exposure prophylaxis, treatment recommendations, infant formulations, generics, and treatment of opportunistic infections.

Acute HIV Infection --- New York City, 2008

This report discusses the medical approach to treating people with acute human immunodeficiency virus (HIV) infection (AHI), a highly infectious phase of the disease, in New York City. It explains that AHI contributes to HIV transmission, as it is associated with a high level of viremia, although antibody tests may be negative or indeterminate.

HIV Infection Among Injection-Drug Users --- 34 States, 2004--2007

In this report, the Centers for Disease Control and Prevention (CDC) analyzed data from the national notifiable disease reporting system for 2004-2007 from the 34 states with confidential name-based HIV reporting since 2003. Data represent injecting drug users (IDUs) who received a new diagnosis of HIV infection, regardless of when the infection was acquired and excluding IDUs categorized as men who have sex with men. Number and percentage of IDUs who were diagnosed with HIV were estimated by sex, age, race/ethnicity, and area of residence at the time of diagnosis.

TB/HIV: Report of the Meeting Organized by the World Health Organization in Collaboration with the TB/HIV Working Group of the Stop TB Partnership

This report provides information on the meeting “From Mekong to Bali: The Scale-up of TB/HIV Collaborative Activities in Asia Pacific,” which was organized by the World Health Organization (WHO) in collaboration with the TB/HIV Working Group of the Stop TB Partnership. There were 127 participants from 18 countries and participants from all the countries with high TB and HIV burdens. Participants described experiences and best practices. The report summarizes key outcomes, conclusions, and recommendations for scale-up of TB/HIV activities in Asia-Pacific.

Guidelines for Prevention and Treatment of Opportunistic Infections among HIV-Infected Children

These guidelines are recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. It targets clinicians and provides guidelines for preventing and treating opportunistic infections (OIs) among HIV-infected children.

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

This MMWR issue updates and combines earlier guidelines (published 2002 and 2004) for the prevention and treatment of opportunistic infections (OIs) in adults and adolescents infected with HIV. The guidelines were developed by a panel of specialists from the United States government and academic institutions and are intended for use by clinicians and other health care providers, HIV-infected patients, and policy makers in the United States. They address OIs that occur in the United States and five OIs that might be acquired during international travel.

Diagnoses of HIV Infection and AIDS among Adolescents and Young Adults in the United States and 5 U.S. Dependent Areas, 2006–2009

This report complements the 2009 HIV Surveillance Report by presenting additional data on persons 13-24 years old from the 45 areas (40 states and 5 US dependent areas) with confidential name-based HIV infection reporting since at least January 2006. It also includes the statistics reported to the CDC through 2009.

Syringe Exchange Programs – United States, 2008

This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.

Diabetes Mellitus and HIV

This visual file consists of 37 slides on the medical case management of diabetes mellitus and HIV. It explains the two types of diabetes, the class of HIV drugs that cause kidney problems or worsening of diabetes, the symptoms of peripheral neuropathy, and effective treatment. The online link can be found at http://aidsetc.org/aidsetc?page=etres-display&resource=etres-529.